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http://dx.doi.org/10.1016/j.jfma.201A rare but severe complication, intestinal necrosis, has been reported after sodium polysty-
rene sulfonate (SPS; Kayexalate) and sorbitol intake. Some case reports described bowel perfo-
ration following calcium polystyrene sulfonate (CPS; Kalimate) administration. We report a
case of ileum and colon perforation following peritoneal dialysis-related peritonitis and
high-dose Kalimate in a 59-year-old female patient. The patient had a history of hypertension,
diabetes mellitus, and end-stage renal disease (ESRD). During hospitalization for peritoneal
dialysis-related peritonitis, she developed hyperkalemia, and Kalimate was administered
orally. However, severe abdominal distension and pain occurred just one day after Kalimate
intake. An urgent surgery disclosed several perforations in the ileum and sigmoid colon. Pathol-
ogy of the resected gut showed transmural necrosis and perforation with basophilic angulated
crystals. The patient finally expired during hospitalization due to refractory septic shock.
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ephrology, Department of Internal Medicine, National Taiwan University Hospital, Number 7, Chung-
tw (T.-W. Kao).
ight ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
3.02.006
Figure 1 Microphotograph of Kalimate crystals. Basophilic
angulated crystals are seen extended from the ulcerated
luminal surface into the transmural region of the ileum (he-
matoxylin and eosin stain 100).
Figure 2 Numerous pseudohyphae and spore-like bodies,
morphologically compatible with Candida species, are
observed in the necrotic debris (Grocott-Gomori’s methena-
mine silver stain 100).
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Hyperkalemia, a common electrolyte disorder in hospital-
ized patients, may be treated with cation-exchange resins.
Though rare, a few previous reports disclosed bowel
perforation after the combined use of sodium polystyrene
sulfonate and sorbital. Sorbital has been shown to have
additional toxic effects on bowel mucosa. Here we present
a patient with ileum and colon perforation after using
calcium polystyrene sulfonate alone for only one day.
Case report
A 59-year-old woman was admitted to our hospital because
of abdominal pain and cloudy peritoneal dialysate for 1 day.
Her medical history included hypertension, type 2 diabetes
mellitus, myocardial infarction, peripheral artery occlusive
disease, and end-stage renal disease (ESRD) under contin-
uous ambulatory peritoneal dialysis (CAPD) since January
2011. Several days before admission, she had suffered from
a low-grade fever, followed by diffuse abdominal pain,
diarrhea, and cloudy peritoneal dialysate. At our emer-
gency department, her Glasgow Coma Scale was E2V2M5,
body temperature was 35.9C, pulse rate was 85 beats per
minute, and blood pressure was 120/62 mmHg. On exami-
nation, her abdomen was soft with diffuse tenderness and
hypoactive bowel sounds. The peritoneal fluid analysis
revealed a total nuclear cell count of 2100 cells/mL with
96% polymorphonuclear leukocytes, and a Gram stain
(Sancordon Inc., Taipei, Taiwan) showed no bacteria. Her
serum albumin level was only 2.1 g/dL. Empirical intra-
peritoneal antibiotic treatment with cefazolin (Xindong,
Taoyuan, Taiwan) and ceftazidime (China Chemical &
Pharmaceutical Co., Ltd., Hsinchu, Taiwan) was adminis-
tered under the impression of peritoneal dialysis-related
peritonitis.
During the initial 10 days of her hospitalization, inter-
mittent fever and abdominal pain were noted, and the
antibiotics were replaced with intravenous imipenem
(Merck Sharp & Dohme Inc., White house, USA) and dap-
tomycin (Hospira, Illinois, USA) on day 10. A further
abdominal computed tomography scan was performed to
exclude secondary peritonitis. Although there was no evi-
dence of intraabdominal infection or bowel perforation,
nonmechanical ileus was noted and treatment was thus
given. On day 11, intraperitoneal fluconazole (Pfizer PGM,
Paris, France) was added due to the presence of yeasts
found on the Gram-stained smear of the dialysate. On day
12, the Tenckhoff catheter was removed due to probable
fungal peritonitis. On day 15, routine dialysate cultures
yielded vancomycin-resistant Enterococcus faecium and
Candida tropicalis.
On day 19, hyperkalemia (6.0 mmol/L) was noted. Cal-
cium polystyrene sulfonate (CPS; Kalimate; 15 g; Kowa,
Tokyo, Japan) was administered orally four times daily.
However, severe abdominal pain and hypotension devel-
oped on day 21. Ascites was tapped, and it looked like fecal
material. A second computed tomography scan of the
abdomen revealed pneumoperitoneum. Urgent surgery
disclosed several perforated lesions in the ileum and sig-
moid colon as well as a massive amount of yellowish fecalmaterial inside the peritoneum. Eventually, partial ileum
resection, sigmoid colon repair, and ileostomy were per-
formed. Pathology of the resected gut reported transmural
necrosis and perforation with basophilic angulated crystals
extending from the ulcerated luminal surface into the
transmural region of ileum (Fig. 1). Numerous pseudohy-
phae and spore-like bodies compatible with candida
infection were also observed in the necrotic debris (Fig. 2).
The postoperative course was complicated by an anasto-
motic leak, and the patient expired on day 39 due to re-
fractory septic shock.
Discussion
Ion-exchange resins were first synthesized in 1935 and used
as a treatment for medical patients in 1961. Kalimate is an
ion-exchange resin frequently prescribed to treat hyper-
kalemia. To the best of our knowledge, only four cases of
1010 C.-C. Kao et al.Kalimate-induced intestinal ulcers have been published.1e4
Our case is the first to document bowel necrosis with
transmural incarceration of Kalimate crystals in the ileum,
combined with candida infection.
In the literature, sorbitol is thought to be the main
contributor to intestinal necrosis associated with the use of
an ion-exchange resin. According to Lillemoe et al,5 the
addition of sorbitol to polystyrene sulfonate is an important
factor in colonic mucosa toxicity in uremic rats. Sorbitol
may cause osmotic injury by altering the hemodynamic of
the bowel wall.6 It also exerts a direct toxic effect on
colonic mucosa by stimulating prostaglandin release.7 So-
dium polystyrene sulfonate (SPS; Kayexalate, Sanofi-Syn-
thelabo, Surrey, England, UK) was reported to cause upper
gastrointestinal mucosa erosions or ulcers in 82% of the
patients in a case series.8 The precise mechanism of
mucosal damage in patients receiving resin in sorbitol re-
mains uncertain.
All of the previous cases presented with abdominal pain
and had different anatomical involvement of the small and
large intestines after the use of Kalimate: one of the cases
had developed jejunal perforations; one had diffuse sig-
moid colon and rectum mucosal necrosis; one had colon
ulcer and sigmoidovesical fistula; and one had proximal
ascending colon lesion. Our patient’s lesions were located
in the ileum and sigmoid colon, and the former site has not
been reported previously. This shows that the entire small
and large intestines may be involved.
The incidence of resin-induced intestinal injury has been
estimated to be 0.27e1.8%.9 The risk factors of resin-
induced intestinal necrosis include postoperation,
obstructive bowel disease, critical illness, hypovolemia,
hypotension, coagulation disorder, immunosuppression,
and ESRD. ESRD may predispose patients to intestinal ne-
crosis through intradialytic hypotension, elevated prosta-
glandin production, hyperreninemia, and localized colonic
mesenteric vasospasm. Owing to severe abdominal pain
soon after the use of Kalimate in our patient, we assumed
that Kalimate was the cause of bowel perforation. The
observation of angulated crystals of Kalimate with a char-
acteristic crystalline mosaic pattern is crucial to diagnose
Kalimate-associated mucosal necrosis.8
It is well known that mechanical intestinal obstruction is
a contraindication to Kalimate administration. Based on
what happened to our patient, we further suggest not giv-
ing Kalimate to patients with on-going or just-treated
nonmechanical obstructive ileus. In general, resin-related
intestinal necrosis develops more slowly after oral admin-
istration than after enema administration. Our patient had
rapid bowel perforation probably due to the presence of
concomitant fungal peritonitis. There are no presumed
limits for Kalimate intake. The Kalimate doses causing
bowel perforation range from 60 g per day to 105 g per day
in the literature. We suggest that large doses of Kalimateshould be used with caution, especially in renal failure and
critically ill patients.
Conclusion
Physicians should be aware of the rare complication of
bowel necrosis following the administration of ion-
exchange resins. Large doses of SPS or CPS should be used
with caution, especially in patients with renal failure and
critical illness.
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